World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
21061
World Ranking
8992
National Ranking
3995

Roy R. Lobb publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Roy R. Lobb sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 156 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Roy R. Lobb D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Roy R. Lobb sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Roy R. Lobb is affiliated with Biogen in the United States. Their research primarily focuses on medical and biochemical fields, with specializations in oncology, molecular biology, genetics, immunology, and organic chemistry.

The scientist's work covers several main research topics:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Biosimilars and Bioanalytical Methods
  • Enzyme function and inhibition
  • Peptidase Inhibition and Analysis
  • Click Chemistry and Applications

Roy R. Lobb has contributed to multiple peer-reviewed papers, including:

  • "Anti-CD19 CAR T cells potently redirected to kill solid tumor cells," 2021, published in PLoS ONE
  • "Engineered protein-small molecule conjugates empower selective enzyme inhibition," 2021, published in Cell chemical biology
  • "Engineered protein-small molecule conjugates empower selective enzyme inhibition," 2021, published in bioRxiv (Cold Spring Harbor Laboratory)
  • "CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma," 2022, published in OncoImmunology
  • "A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer," 2023, published in Cells

The scientist frequently publishes in venues such as Regular and Young Investigator Award Abstracts, bioRxiv (Cold Spring Harbor Laboratory), PLoS ONE, Cell chemical biology, and OncoImmunology.

Frequent co-authors collaborating with Roy R. Lobb include:

  • Paul D. Rennert
  • Christine Ambrose
  • Lihe Su
  • Lan Wu
  • Benjamin J. Hackel

The publications reflect a sustained contribution to the oncology domain and related molecular biology studies. The work on CAR-T cell therapy is particularly prominent, showing a focus on developing and optimizing cellular therapies for cancer treatment. Research on enzyme inhibition and small molecule conjugates further highlights interest in molecular mechanisms and therapeutic targeting.

Best Publications

  • Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes.

    Laurelee Osborn;Catherine Hession;Richard Tizard;Cornelia Vassallo

  • VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site

    Mariano J. Elices;Laurelee Osborn;Yoshikazu Takada;Carol Crouse

  • Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets.

    Theresa Palabrica;Roy Lobb;Barbara C. Furie;Mark Aronovitz

  • The pathophysiologic role of alpha 4 integrins in vivo.

    R R Lobb;M E Hemler

  • Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.

    D K Podolsky;R Lobb;N King;C D Benjamin

  • ELFT: a gene that directs the expression of an ELAM-1 ligand.

    Susan E. Goelz;Catherine Hession;Deborah Goff;Beth Griffiths

  • Amino acid sequence of human tumor derived angiogenin.

    Strydom Dj;Fett Jw;Lobb Rr;Alderman Em

  • Subsecond Induction of α4 Integrin Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell Adhesion Molecule 1 under Flow Conditions

    Valentin Grabovsky;Sara Feigelson;Chun Chen;Diederik A. Bleijs

  • Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils.

    S K Lo;S Lee;R A Ramos;R Lobb

  • Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1

    T Carlos;N Kovach;B Schwartz;M Rosa

  • Purification of heparin-binding growth factors.

    R. R. Lobb;J. W. Harper;J. W. Fett;J. W. Fett

  • Purification and characterization of heparin-binding endothelial cell growth factors.

    Roy Lobb;Joachim Sasse;Robert Sullivan;Yuen Shing

  • Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.

    W M Abraham;M W Sielczak;A Ahmed;A Cortes

  • Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.

    Peter F. Weller;Thomas H. Rand;Susan E. Goelz;Gloria Chi-Rosso

  • Expression of vascular adhesion molecules in inflammatory bowel disease.

    Mitsuru Koizumi;Norval King;Roy Lobb;Christopher Benjamin

  • Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.

    Rafael Pulido;Mariano J. Elices;Miguel R. Campanero;Laurelee Osborn

  • Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis

    Antonin R. de Fougerolles;Andrew G. Sprague;Cheryl L. Nickerson-Nutter;Gloria Chi-Rosso

  • Selective, tight-binding inhibitors of integrin α4β1 that inhibit allergic airway responses

    K c Lin;H S Ateeq;S H Hsiung;L T Chong

  • VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis.

    Miquel Sans;Julián Panés;Esther Ardite;J.Ignasi Elizalde

  • Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life.

    Deborah H. Damon;Roy R. Lobb;Patricia A. D'Amore;John A. Wagner

Frequent Co-Authors

Linda C. Burkly
Linda C. Burkly Biogen (United States)
Christine Ambrose
Christine Ambrose Biogen (United States)
Martin E. Hemler
Martin E. Hemler Harvard University
R. Blake Pepinsky
R. Blake Pepinsky Biogen (United States)
Sussan Nourshargh
Sussan Nourshargh Queen Mary University of London
Ronen Alon
Ronen Alon Weizmann Institute of Science
James F. Riordan
James F. Riordan Harvard University
Daniel K. Podolsky
Daniel K. Podolsky The University of Texas at Dallas
Bert L. Vallee
Bert L. Vallee Harvard University
Juan J. Calvete
Juan J. Calvete Spanish National Research Council

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Roy R. Lobb

Trending Scientists